| Literature DB >> 8285737 |
A Torres1.
Abstract
Physicians increasingly use Food and Drug Administration (FDA)-approved drugs (medication) for unlabeled (off-label) indications. The ethical and legal implications of these actions are not always clear. In this article, I examine the common law and federal statutory regulations concerning this issue and also explore some of the ethical and financial issues involved.Keywords: Food, Drug, and Cosmetic Act; Legal Approach; Professional Patient Relationship
Mesh:
Substances:
Year: 1994 PMID: 8285737
Source DB: PubMed Journal: Arch Dermatol ISSN: 0003-987X